Literature DB >> 201367

Initial reaction of 3-ethyoxy-2-oxobutyraldehyde bis(thiosemicarbazonato) copper(II) with Ehrlich ascites tumor cells.

D T Minkel, D H Petering.   

Abstract

The antineoplastic agent, 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazonato) copper(II), undergoes a pseudo-first-order decomposition in the presence of viable Ehrlich ascites tumor cells. Physical and chemical methods show that the copper is reduced in this process, that thiols are involved in the reaction, and that the thiosemicarbazone ligand is displaced from the copper ion. The widespread distribution of the cell-bound copper suggests several modes of cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 201367

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Preferential inhibition of ribonucleic acid synthesis by a new thiosemicarbazone possessing antibacterial and antiparasitic properties.

Authors:  R E Brown; F A Stancato; A D Wolfe
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

Review 2.  PET imaging of cardiac hypoxia: opportunities and challenges.

Authors:  M G Handley; R A Medina; E Nagel; P J Blower; R Southworth
Journal:  J Mol Cell Cardiol       Date:  2011-07-14       Impact factor: 5.000

3.  Differential mechanism of retention of Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM) by brain and tumor: a novel radiopharmaceutical for positron emission tomography imaging.

Authors:  Y Fujibayashi; H Taniuchi; K Wada; Y Yonekura; J Konishi; A Yokoyama
Journal:  Ann Nucl Med       Date:  1995-02       Impact factor: 2.668

4.  Metal binding drugs induce synthesis of four proteins in normal cells.

Authors:  W Levinson; J Idriss; J Jackson
Journal:  Biol Trace Elem Res       Date:  1979-03       Impact factor: 3.738

5.  Ribonucleotide reductase inhibition by metal complexes of Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone): a combined experimental and theoretical study.

Authors:  Ana Popović-Bijelić; Christian R Kowol; Maria E S Lind; Jinghui Luo; Fahmi Himo; Eva A Enyedy; Vladimir B Arion; Astrid Gräslund
Journal:  J Inorg Biochem       Date:  2011-07-31       Impact factor: 4.155

6.  ESR of copper and iron complexes with antitumor and cytotoxic properties.

Authors:  W E Antholine; B Kalyanaraman; D H Petering
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031

7.  Modification of intracellular glutathione status does not change the cardiac trapping of (64)Cu(ATSM).

Authors:  Fiona Shaughnessy; Erika Mariotti; Karen P Shaw; Thomas R Eykyn; Philip J Blower; Richard Siow; Richard Southworth
Journal:  EJNMMI Res       Date:  2014-08-01       Impact factor: 3.138

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.